Work is performed in the subgroup PRELIM in Translational Molecular Imaging of Cancer(Prof. McCormack) and in the Signalling targeted therapy group(Prof. Gjertsen)
Affiliated with CCBIO
- (2019). A kinase inhibitor with anti-Pim kinase activity is a potent and selective cytotoxic agent toward acute myeloid leukemia. Molecular Cancer Therapeutics. 567-578.
- (2016). The past, present and future subclassification of patients with acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 6-19.
- B.Sc in Biology at the University of Bergen (2013)
- M.Sc in Biomedicine - Medical cell Biology at the University of Bergen (2015) with the thesis "Exploring the anti-leukaemic effect of the small-molecule dynamin GTPase inhibitor; Dynasore, in Acute Myeloid Leukaemia."